Correction
Death-receptor activation halts clathrin-dependent endocytosis
Paper Information
Record ID:
64569
Author(s):
Journal:
Publication Date:
July 05, 2006
Retraction Date:
January 03, 2025
(<1 year years ago)
Subjects:
Institutions:
- Department of Research Administration, Genentech, Inc., South San Francisco, CA 94080
- Department of Molecular Oncology, Genentech, Inc., South San Francisco, CA 94080
- Department of Protein Chemistry, Genentech, Inc., South San Francisco, CA 94080
- Cell Microscopy Center, Department of Cell Biology and Institute for Biomembranes, University Medical Center Utrecht, 3584CX, Utrecht, The Netherlands
Countries:
Article Type:
Publisher:
National Academy of Sciences (NAS)
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Correction Details
Citations (111)
111
Total Citations0
Post-Retraction111
Pre-Retraction0
Same DayEfficient Drug Delivery and Induction of Apoptosis in Colorectal Tumors Using a Death Receptor 5-Targeted Nanomedicine
Daniela Schmid, François Fay, Donna M. Small et al. (11 authors)
Molecular Therapy
Open Access
Published: Sep 2014
43 citations
43 citations
3769 days before retraction
Regulated Cell Death: Signaling and Mechanisms
Avi Ashkenazi, Guy S. Salvesen
Annual Review of Cell and Developmental Biology
Open Access
Published: Aug 2014
254 citations
254 citations
3786 days before retraction
Paper citing Death-receptor activation halts clathrin-dependent...
Unknown Authors
Unknown Journal
Published: May 2014
3870 days before retraction
E-Cadherin Couples Death Receptors to the Cytoskeleton to Regulate Apoptosis
Min Lu, Scot A. Marsters, Xiaofen Ye et al. (6 authors)
Molecular Cell
Open Access
Published: May 2014
93 citations
93 citations
3872 days before retraction
YM155 sensitizes triple-negative breast cancer to membrane-bound TRAIL through p38 MAPK- and CHOP-mediated DR5 upregulation
Marzia Pennati, Stefania Sbarra, Michelandrea De Cesare et al. (10 authors)
International Journal of Cancer
Open Access
Published: May 2014
31 citations
31 citations
3873 days before retraction
Apoptosis Initiation Through the Cell-Extrinsic Pathway
Pradeep M. Nair, Min Lu, Sean Petersen et al. (4 authors)
Methods in enzymology on CD-ROM/Methods in enzymology
Published: Jan 2014
100 citations
100 citations
4020 days before retraction
Apoptosis: the extrinsic pathway
Xinchen Teng, J. Marie Hardwick
Cambridge University Press eBooks
Published: Dec 2013
1 citation
1 citation
4033 days before retraction
Ehd3, a regulator of vesicular trafficking, is silenced in gliomas and functions as a tumor suppressor by controlling cell cycle arrest and apoptosis
Sahiti Chukkapalli, Mohamed Amessou, Hafedh Dekhil et al. (10 authors)
Carcinogenesis
Published: Dec 2013
21 citations
21 citations
4048 days before retraction
Paper citing Death-receptor activation halts clathrin-dependent...
Unknown Authors
Unknown Journal
Published: Jul 2013
4194 days before retraction
Membrane Trafficking of Death Receptors: Implications on Signalling
Wulf Schneider‐Brachert, Ulrike Heigl, Martin Ehrenschwender
International Journal of Molecular Sciences
Open Access
Published: Jul 2013
48 citations
48 citations
4194 days before retraction
Cells surviving fractional killing by TRAIL exhibit transient but sustainable resistance and inflammatory phenotypes
Deborah A. Flusberg, Jérémie Roux, Sabrina L. Spencer et al. (4 authors)
Molecular Biology of the Cell
Open Access
Published: May 2013
93 citations
93 citations
4243 days before retraction
A SILAC-based Approach Identifies Substrates of Caspase-dependent Cleavage upon TRAIL-induced Apoptosis
Gabriele Stoehr, Christoph Schaab, Johannes Graumann et al. (4 authors)
Molecular & Cellular Proteomics
Open Access
Published: Jan 2013
30 citations
30 citations
4371 days before retraction
Ubiquitination by the Membrane-associated RING-CH-8 (MARCH-8) Ligase Controls Steady-state Cell Surface Expression of Tumor Necrosis Factor-related Apoptosis Inducing Ligand (TRAIL) Receptor 1*
Bert van de Kooij, Inge Verbrugge, Evert de Vries et al. (8 authors)
Journal of Biological Chemistry
Open Access
Published: Jan 2013
80 citations
80 citations
4377 days before retraction
Absence of death receptor translocation into lipid rafts in acquired TRAIL-resistant NSCLC cells
Wen Ouyang, Chunxu Yang, Simin Zhang et al. (9 authors)
International Journal of Oncology
Open Access
Published: Dec 2012
24 citations
24 citations
4397 days before retraction
TRAF2 Sets a Threshold for Extrinsic Apoptosis by Tagging Caspase-8 with a Ubiquitin Shutoff Timer
François Gonzalvez, David A. Lawrence, Becky Yang et al. (10 authors)
Molecular Cell
Open Access
Published: Nov 2012
146 citations
146 citations
4439 days before retraction
Mislocalization of death receptors correlates with cellular resistance to their cognate ligands in human breast cancer cells
Junjie Chen, Hui Shen, Leslie A. Rivera Rosado et al. (6 authors)
Oncotarget
Open Access
Published: Aug 2012
56 citations
56 citations
4520 days before retraction
Breast Cancer Proteome Takes More Than Two to Tango on TRAIL: Beat Them at Their Own Game
Ammad Ahmad Farooqı, Sundas Fayyaz, Muhammad Tahir et al. (5 authors)
The Journal of Membrane Biology
Published: Aug 2012
6 citations
6 citations
4523 days before retraction
Ligand binding and receptor network formation in the tumor necrosis factor superfamily.
Christopher C. Valley
Unknown Journal
Published: Jul 2012
4569 days before retraction
Ganglioside GD3 as a Raft Component in Cell Death Regulation
Maurizio Sorice, Tina Garofalo, Roberta Misasi et al. (6 authors)
Anti-Cancer Agents in Medicinal Chemistry
Published: Apr 2012
39 citations
39 citations
4660 days before retraction
Removal of Syndecan-1 Promotes TRAIL-Induced Apoptosis in Myeloma Cells
Yung‐Hsuan Wu, Chenying Yang, Wen-Li Chien et al. (5 authors)
The Journal of Immunology
Open Access
Published: Feb 2012
27 citations
27 citations
4717 days before retraction
Global kinetic analysis of proteolysis via quantitative targeted proteomics
Nicholas J. Agard, Sami Mahrus, Jonathan C. Trinidad et al. (6 authors)
Proceedings of the National Academy of Sciences
Open Access
Published: Jan 2012
122 citations
122 citations
4729 days before retraction
Targeting the Apo2L/TRAIL system for the therapy of autoimmune diseases and cancer
Luis Martínez‐Lostao, Isabel Marzo, Alberto Anel et al. (4 authors)
Biochemical Pharmacology
Published: Jan 2012
51 citations
51 citations
4750 days before retraction
TRAIL and vitamins: opting for keys to castle of cancer proteome instead of open sesame
Ammad Ahmad Farooqı, Shahzad Bhatti, Muhammad Ismail
Cancer Cell International
Open Access
Published: Jan 2012
9 citations
9 citations
4751 days before retraction
Efficacy and Mechanistic Evaluation of Tic10, A Novel Antitumor Agent
Joshua E. Allen
Unknown Journal
Published: Jan 2012
4751 days before retraction
TRAIL receptor signaling and therapeutic option in bone tumors: the trap of the bone microenvironment.
Gaëlle Picarda, Valérie Trichet, Stéphane Téletchéa et al. (5 authors)
PubMed
Published: Jan 2012
25 citations
25 citations
4751 days before retraction
GDP-mannose-4,6-dehydratase (GMDS) Deficiency Renders Colon Cancer Cells Resistant to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Receptor- and CD95-mediated Apoptosis by Inhibiting Complex II Formation
Kenta Moriwaki, Shinichiro Shinzaki, Eiji Miyoshi
Journal of Biological Chemistry
Open Access
Published: Oct 2011
51 citations
51 citations
4818 days before retraction
Importin β1 Protein-mediated Nuclear Localization of Death Receptor 5 (DR5) Limits DR5/Tumor Necrosis Factor (TNF)-related Apoptosis-inducing Ligand (TRAIL)-induced Cell Death of Human Tumor Cells
Yuko Kojima, M. NAKAYAMA, Takashi Nishina et al. (8 authors)
Journal of Biological Chemistry
Open Access
Published: Oct 2011
66 citations
66 citations
4822 days before retraction
Cell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cells
N. Mazurek, James C. Byrd, Yu Sun et al. (7 authors)
Cell Death and Differentiation
Open Access
Published: Sep 2011
92 citations
92 citations
4851 days before retraction
Redistribution of DR4 and DR5 in lipid rafts accounts for the sensitivity to TRAIL in NSCLC cells
Conghua Xie
International Journal of Oncology
Open Access
Published: Jul 2011
30 citations
30 citations
4918 days before retraction
Targeting Apo2L/TRAIL receptors by soluble Apo2L/TRAIL
Pamela M. Holland
Cancer Letters
Published: Jan 2011
52 citations
52 citations
5107 days before retraction
LETHAL WEAPONS - Novel approaches for receptor-targeted cancer cell elimination
Emilia Peuhu
Unknown Journal
Published: Dec 2010
5131 days before retraction
Subcellular compartmentalization of TNF receptor-1 and CD95 signaling pathways
Vladimir Tchikov, Uwe Bertsch, Jürgen Fritsch et al. (5 authors)
European Journal of Cell Biology
Published: Dec 2010
47 citations
47 citations
5140 days before retraction
Impact of death receptor signaling on the malignancy of pancreatic ductal adenocarcinoma
Christian Röder, Anna Trauzold, Holger Kalthoff
European Journal of Cell Biology
Published: Dec 2010
39 citations
39 citations
5144 days before retraction
Combined treatment with TRAIL and PPARγ ligands overcomes chemoresistance of ovarian cancer cell lines
Karen Bräutigam, Julia Biernath-Wüpping, Dirk Bauerschlag et al. (8 authors)
Journal of Cancer Research and Clinical Oncology
Published: Sep 2010
31 citations
31 citations
5211 days before retraction
New insights into apoptosis signaling by Apo2L/TRAIL
François Gonzalvez, Avi Ashkenazi
Oncogene
Open Access
Published: Jun 2010
351 citations
351 citations
5324 days before retraction
Role of individual caspases induced by astrovirus on the processing of its structural protein and its release from the cell through a non-lytic mechanism
Ma. del Rocío Baños-Lara, Ernesto Méndez
Virology
Open Access
Published: Mar 2010
61 citations
61 citations
5393 days before retraction
Playing the DISC: Turning on TRAIL death receptor-mediated apoptosis in cancer
Bodvaël Pennarun, Annemieke Meijer, Elisabeth G.E. de Vries et al. (6 authors)
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Published: Dec 2009
159 citations
159 citations
5506 days before retraction
Repeated Treatment with Subtoxic Doses of TRAIL Induces Resistance to Apoptosis through Its Death Receptors in MDA-MB-231 Breast Cancer Cells
Tatsushi Yoshida, Yaqin Zhang, Leslie A. Rivera Rosado et al. (4 authors)
Molecular Cancer Research
Open Access
Published: Oct 2009
53 citations
53 citations
5553 days before retraction
Tickets to ride: selecting cargo for clathrin-regulated internalization
Linton M. Traub
Nature Reviews Molecular Cell Biology
Published: Aug 2009
531 citations
531 citations
5614 days before retraction
Phenylarsine oxide interferes with the death inducing signaling complex and inhibits tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induced apoptosis
Xiaoming Sun, Ana Canda-Sánchez, Ganesh R. Manjeri et al. (5 authors)
Experimental Cell Research
Published: May 2009
4 citations
4 citations
5704 days before retraction
Paper citing Death-receptor activation halts clathrin-dependent...
Unknown Authors
Unknown Journal
Published: May 2009
5712 days before retraction
Cullin3-Based Polyubiquitination and p62-Dependent Aggregation of Caspase-8 Mediate Extrinsic Apoptosis Signaling
Zhaoyu Jin, Yun Li, Robert Pitti et al. (7 authors)
Cell
Open Access
Published: May 2009
573 citations
573 citations
5726 days before retraction
Death Receptor 5 Internalization Is Required for Lysosomal Permeabilization by TRAIL in Malignant Liver Cell Lines
Yuko Akazawa, Justin L. Mott, Steven F. Bronk et al. (12 authors)
Gastroenterology
Open Access
Published: Mar 2009
73 citations
73 citations
5778 days before retraction
Impact of TNF-R1 and CD95 Internalization on Apoptotic and Antiapoptotic Signaling
Stefan Schütze, Wulf Schneider‐Brachert
Results and problems in cell differentiation
Published: Jan 2009
30 citations
30 citations
5846 days before retraction
Chapter 3 The TRAIL to Targeted Therapy of Breast Cancer
Monzur Rahman, Janet G. Pumphrey, Stanley Lipkowitz
Advances in cancer research
Open Access
Published: Jan 2009
73 citations
73 citations
5846 days before retraction
TRAIL Resistance of Breast Cancer Cells Is Associated with Constitutive Endocytosis of Death Receptors 4 and 5
Yaqin Zhang, Baolin Zhang
Molecular Cancer Research
Open Access
Published: Dec 2008
233 citations
233 citations
5877 days before retraction
Fas Death Receptor Enhances Endocytic Membrane Traffic Converging into the Golgi Region
Mauro Degli Esposti, Julien Tour, Sihem Ouasti et al. (7 authors)
Molecular Biology of the Cell
Open Access
Published: Nov 2008
28 citations
28 citations
5881 days before retraction
Directing cancer cells to self-destruct with pro-apoptotic receptor agonists
Avi Ashkenazi
Nature Reviews Drug Discovery
Published: Nov 2008
415 citations
415 citations
5901 days before retraction
Ligand-Based Targeting of Apoptosis in Cancer: The Potential of Recombinant Human Apoptosis Ligand 2/Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (rhApo2L/TRAIL)
Avi Ashkenazi, Pamela M. Holland, S. Gail Eckhardt
Journal of Clinical Oncology
Published: Jul 2008
413 citations
413 citations
6014 days before retraction
Regulation of TNFR1 and CD95 signalling by receptor compartmentalization
Stefan Schütze, Vladimir Tchikov, Wulf Schneider‐Brachert
Nature Reviews Molecular Cell Biology
Published: Jun 2008
290 citations
290 citations
6050 days before retraction
Related Records
This article has multiple records in the database due to different notices:
Record #64568
May 15, 2025Quick Stats
Total Citations:
111
Years Since Retraction:
<1 year
Open Access:
Yes
Last Checked:
Jul 24, 2025